Compare $DXCM vs $IDXX | Chartloom

Compare

$DXCM vs $IDXX

Dexcom Inc · IDEXX Laboratories Inc

DXCM

Dexcom Inc

IDXX

IDEXX Laboratories Inc

Compare $DXCM vs $IDXX

Comparing Dexcom Inc and IDEXX Laboratories Inc

DXCMDexcom Inc

IDXXIDEXX Laboratories Inc

DXCMDexcom Inc

Market cap

$32.46B

P/E (TTM)

32.82x

Forward P/E (NTM)

29.31x

Forward P/S (NTM)

5.79x

Rev growth (TTM)

15.5%

YTD performance

26.4%

52W performance

24.1%

FCF yield

4.3%

IDXXIDEXX Laboratories Inc

Market cap

$40.86B

P/E (TTM)

36.05x

Forward P/E (NTM)

32.49x

Forward P/S (NTM)

8.19x

Rev growth (TTM)

12.8%

YTD performance

-22.7%

52W performance

-17.8%

FCF yield

3.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DXCM

IDXX

Detailed metrics comparison

DXCM

Dexcom Inc

IDXX

IDEXX Laboratories Inc

Market Cap

DXCM$32.46B

IDXX$40.86B

Enterprise Value

DXCM$32.65B

IDXX$41.63B

Price

DXCM$84.11

IDXX$518.00

P/E Ratio

DXCM32.82x

IDXX36.05x

P/S Ratio

DXCM6.53x

IDXX8.97x

EV/Sales

DXCM6.57x

IDXX9.14x

EV/EBITDA

DXCM21.12x

IDXX25.78x

P/B Ratio

DXCM12.29x

IDXX25.33x

P/FCF Ratio

DXCM23.10x

IDXX33.03x

EV/FCF

DXCM23.24x

IDXX33.65x

PEG Ratio

DXCM1.54x

IDXX2.78x

Forward P/E (NTM)

DXCM29.31x

IDXX32.49x

Forward P/S (NTM)

DXCM5.79x

IDXX8.19x

Revenue (TTM)

DXCM$4.97B

IDXX$4.55B

Revenue Growth (YoY)

DXCM15.5%

IDXX12.8%

Forward Rev Growth

DXCM10.8%

IDXX8.8%

Gross Margin (TTM)

DXCM64.3%

IDXX62.4%

Operating Margin (TTM)

DXCM22.9%

IDXX32.0%

EBITDA Margin (TTM)

DXCM30.1%

IDXX35.4%

Net Margin (TTM)

DXCM20.1%

IDXX25.0%

FCF Margin (TTM)

DXCM28.3%

IDXX27.2%

Net Income (TTM)

DXCM$1,000M

IDXX$1.14B

FCF (TTM)

DXCM$1.41B

IDXX$1.24B

EPS (TTM)

DXCM$2.56

IDXX$14.37

ROE (TTM)

DXCM36.2%

IDXX72.0%

ROA (TTM)

DXCM14.8%

IDXX33.6%

ROIC (TTM)

DXCM22.9%

IDXX45.1%

Cash

DXCM$1.11B

IDXX$197M

Debt

DXCM$1.30B

IDXX$969M

Net Cash/Debt

DXCM$-190M

IDXX$-772M

Current Ratio (TTM)

DXCM1.73x

IDXX1.17x

Quick Ratio (TTM)

DXCM1.40x

IDXX0.82x

Debt/Equity (TTM)

DXCM0.49x

IDXX0.60x

Debt/Assets (TTM)

DXCM0.0%

IDXX0.0%

Interest Coverage (TTM)

DXCMN/A

IDXXN/A

Net Debt/EBITDA (TTM)

DXCM0.00x

IDXX0.00x

Beta

DXCM1.44

IDXX1.56

52W Performance

DXCM24.1%

IDXX-17.8%

YTD Performance

DXCM26.4%

IDXX-22.7%

% from 52W High

DXCM-9.2%

IDXX-32.7%

% from 52W Low

DXCM55.4%

IDXX3.5%

Asset Turnover (TTM)

DXCM0.74x

IDXX1.34x

FCF Yield (TTM)

DXCM4.3%

IDXX3.0%

Earnings Yield (TTM)

DXCM3.1%

IDXX2.8%

Dividend Yield (TTM)

DXCMN/A

IDXXN/A

Rule of 40

DXCM43.8

IDXX39.9

EV/GP/RG

DXCM0.77

IDXX1.52

Ticker research

View DXCM research View IDXX research

Metric	DXCM Dexcom Inc	IDXX IDEXX Laboratories Inc
Market & Valuation
Market Cap	$32.46B	$40.86B
Enterprise Value	$32.65B	$41.63B
Price	$84.11	$518.00
P/E Ratio	32.82x	36.05x
P/S Ratio	6.53x	8.97x
EV/Sales	6.57x	9.14x
EV/EBITDA	21.12x	25.78x
P/B Ratio	12.29x	25.33x
P/FCF Ratio	23.10x	33.03x
EV/FCF	23.24x	33.65x
PEG Ratio	1.54x	2.78x
Forward P/E (NTM)	29.31x	32.49x
Forward P/S (NTM)	5.79x	8.19x
Revenue & Growth
Revenue (TTM)	$4.97B	$4.55B
Revenue Growth (YoY)	15.5%	12.8%
Forward Rev Growth	10.8%	8.8%
Profitability
Gross Margin (TTM)	64.3%	62.4%
Operating Margin (TTM)	22.9%	32.0%
EBITDA Margin (TTM)	30.1%	35.4%
Net Margin (TTM)	20.1%	25.0%
FCF Margin (TTM)	28.3%	27.2%
Net Income (TTM)	$1,000M	$1.14B
FCF (TTM)	$1.41B	$1.24B
EPS (TTM)	$2.56	$14.37
ROE (TTM)	36.2%	72.0%
ROA (TTM)	14.8%	33.6%
ROIC (TTM)	22.9%	45.1%
Financial Health
Cash	$1.11B	$197M
Debt	$1.30B	$969M
Net Cash/Debt	$-190M	$-772M
Current Ratio (TTM)	1.73x	1.17x
Quick Ratio (TTM)	1.40x	0.82x
Debt/Equity (TTM)	0.49x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	1.56
52W Performance	24.1%	-17.8%
YTD Performance	26.4%	-22.7%
% from 52W High	-9.2%	-32.7%
% from 52W Low	55.4%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.74x	1.34x
FCF Yield (TTM)	4.3%	3.0%
Earnings Yield (TTM)	3.1%	2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.8	39.9
EV/GP/RG	0.77	1.52
Ticker research	View DXCM research	View IDXX research

Valuation

P/E Ratio

DXCM

32.82x

IDXX

36.05x

P/S Ratio

DXCM

6.53x

IDXX

8.97x

EV/FCF

DXCM

23.24x

IDXX

33.65x

Growth & revenue

Revenue Growth TTM

DXCM

15.5%

IDXX

12.8%

Forward Revenue Growth

DXCM

10.8%

IDXX

8.8%

Profitability & performance

Gross Margin

DXCM

64.3%

IDXX

62.4%

ROE

IDXX

72.0%

DXCM

36.2%

FCF Yield %

DXCM

4.3%

IDXX

3.0%

52-Week Performance

DXCM

24.1%

IDXX

-17.8%

Detailed metrics comparison

DXCM

Dexcom Inc

IDXX

IDEXX Laboratories Inc

Market Cap

DXCM$32.46B

IDXX$40.86B

Enterprise Value

DXCM$32.65B

IDXX$41.63B

Price

DXCM$84.11

IDXX$518.00

P/E Ratio

DXCM32.82x

IDXX36.05x

P/S Ratio

DXCM6.53x

IDXX8.97x

EV/Sales

DXCM6.57x

IDXX9.14x

EV/EBITDA

DXCM21.12x

IDXX25.78x

P/B Ratio

DXCM12.29x

IDXX25.33x

P/FCF Ratio

DXCM23.10x

IDXX33.03x

EV/FCF

DXCM23.24x

IDXX33.65x

PEG Ratio

DXCM1.54x

IDXX2.78x

Forward P/E (NTM)

DXCM29.31x

IDXX32.49x

Forward P/S (NTM)

DXCM5.79x

IDXX8.19x

Revenue (TTM)

DXCM$4.97B

IDXX$4.55B

Revenue Growth (YoY)

DXCM15.5%

IDXX12.8%

Forward Rev Growth

DXCM10.8%

IDXX8.8%

Gross Margin (TTM)

DXCM64.3%

IDXX62.4%

Operating Margin (TTM)

DXCM22.9%

IDXX32.0%

EBITDA Margin (TTM)

DXCM30.1%

IDXX35.4%

Net Margin (TTM)

DXCM20.1%

IDXX25.0%

FCF Margin (TTM)

DXCM28.3%

IDXX27.2%

Net Income (TTM)

DXCM$1,000M

IDXX$1.14B

FCF (TTM)

DXCM$1.41B

IDXX$1.24B

EPS (TTM)

DXCM$2.56

IDXX$14.37

ROE (TTM)

DXCM36.2%

IDXX72.0%

ROA (TTM)

DXCM14.8%

IDXX33.6%

ROIC (TTM)

DXCM22.9%

IDXX45.1%

Cash

DXCM$1.11B

IDXX$197M

Debt

DXCM$1.30B

IDXX$969M

Net Cash/Debt

DXCM$-190M

IDXX$-772M

Current Ratio (TTM)

DXCM1.73x

IDXX1.17x

Quick Ratio (TTM)

DXCM1.40x

IDXX0.82x

Debt/Equity (TTM)

DXCM0.49x

IDXX0.60x

Debt/Assets (TTM)

DXCM0.0%

IDXX0.0%

Interest Coverage (TTM)

DXCMN/A

IDXXN/A

Net Debt/EBITDA (TTM)

DXCM0.00x

IDXX0.00x

Beta

DXCM1.44

IDXX1.56

52W Performance

DXCM24.1%

IDXX-17.8%

YTD Performance

DXCM26.4%

IDXX-22.7%

% from 52W High

DXCM-9.2%

IDXX-32.7%

% from 52W Low

DXCM55.4%

IDXX3.5%

Asset Turnover (TTM)

DXCM0.74x

IDXX1.34x

FCF Yield (TTM)

DXCM4.3%

IDXX3.0%

Earnings Yield (TTM)

DXCM3.1%

IDXX2.8%

Dividend Yield (TTM)

DXCMN/A

IDXXN/A

Rule of 40

DXCM43.8

IDXX39.9

EV/GP/RG

DXCM0.77

IDXX1.52

Ticker research

View DXCM research View IDXX research

Metric	DXCM Dexcom Inc	IDXX IDEXX Laboratories Inc
Market & Valuation
Market Cap	$32.46B	$40.86B
Enterprise Value	$32.65B	$41.63B
Price	$84.11	$518.00
P/E Ratio	32.82x	36.05x
P/S Ratio	6.53x	8.97x
EV/Sales	6.57x	9.14x
EV/EBITDA	21.12x	25.78x
P/B Ratio	12.29x	25.33x
P/FCF Ratio	23.10x	33.03x
EV/FCF	23.24x	33.65x
PEG Ratio	1.54x	2.78x
Forward P/E (NTM)	29.31x	32.49x
Forward P/S (NTM)	5.79x	8.19x
Revenue & Growth
Revenue (TTM)	$4.97B	$4.55B
Revenue Growth (YoY)	15.5%	12.8%
Forward Rev Growth	10.8%	8.8%
Profitability
Gross Margin (TTM)	64.3%	62.4%
Operating Margin (TTM)	22.9%	32.0%
EBITDA Margin (TTM)	30.1%	35.4%
Net Margin (TTM)	20.1%	25.0%
FCF Margin (TTM)	28.3%	27.2%
Net Income (TTM)	$1,000M	$1.14B
FCF (TTM)	$1.41B	$1.24B
EPS (TTM)	$2.56	$14.37
ROE (TTM)	36.2%	72.0%
ROA (TTM)	14.8%	33.6%
ROIC (TTM)	22.9%	45.1%
Financial Health
Cash	$1.11B	$197M
Debt	$1.30B	$969M
Net Cash/Debt	$-190M	$-772M
Current Ratio (TTM)	1.73x	1.17x
Quick Ratio (TTM)	1.40x	0.82x
Debt/Equity (TTM)	0.49x	0.60x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	1.56
52W Performance	24.1%	-17.8%
YTD Performance	26.4%	-22.7%
% from 52W High	-9.2%	-32.7%
% from 52W Low	55.4%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.74x	1.34x
FCF Yield (TTM)	4.3%	3.0%
Earnings Yield (TTM)	3.1%	2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.8	39.9
EV/GP/RG	0.77	1.52
Ticker research	View DXCM research	View IDXX research